Provider
P34-19 Change to Prior Authorization Requirements for Outpatient Therapies and Chiropractic Services for Commercial and Medicare Products
Program effective Date: Apr 01, 2019
Documents & Forms Results
Displaying 2561 - 2570 of 3097 results
Provider
P26R1-19 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business – Effective May 6, 2019
Program effective Date: Apr 01, 2019
Provider
P36-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Utilization Management Program
Program effective Date: Apr 01, 2019
Provider
P38-19 Change to Outpatient Therapies Prior Authorization Requirements for Medicare Advantage Subscribers
Program effective Date: Apr 01, 2019
Provider
P33-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business
Program effective Date: Apr 01, 2019
Provider
P35-19 Appeals Policy for no Prior Authorization Effective June 3, 2019
Program effective Date: Apr 01, 2019
Provider
QP30-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Program effective Date: Mar 27, 2019
Provider
QP33-19 SmartChoice Program for Fully Insured Commercial Products
Program effective Date: Mar 27, 2019
Provider
QP32-19 Pharmacy Benefit Exclusion for Glyrx-PF, Libtayo, Lumoxiti, Onpattro, Poteligeo, and Xerava
Program effective Date: Mar 27, 2019
Provider
QP34-19 Pharmacy Benefit Exclusion for Antineoplastic and Adjunctive Therapies
Program effective Date: Mar 27, 2019